On the other hand, a significant decrease was observed in the expression of EVMetS mRNA for MasR, a major component of the anti-inflammatory RAS axis, which was inhibited in MetS rats treated with candesartan. The gene discussed is MAS1L; the disease is metabolic syndrome.